UNIVERSITY OF WASHINGTON
IL-15 mediated immune programming in nonhuman primates to improve vaccine efficacy
IL-15 mediated immune programming in nonhuman primates to improve vaccine efficacy is a funding opportunity from UNIVERSITY OF WASHINGTON, up to 189000, closing May 31, 2031.
May 31, 2031
(1765d left)Overview
ABSTRACT: Interleukin (IL)-15, a proinflammatory cytokine, has garnered significant interest for its immunotherapeutic potential, and recently for its role in mediating a protective immune response to a candidate HIV vaccine. IL-15 is a predicted upstream regulatory for the protective immune response elicited by a…